NO140186C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye 2-(2-pyridyl)-3-(p-klorfenyl)-propylaminer - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye 2-(2-pyridyl)-3-(p-klorfenyl)-propylaminer

Info

Publication number
NO140186C
NO140186C NO3807/73A NO380773A NO140186C NO 140186 C NO140186 C NO 140186C NO 3807/73 A NO3807/73 A NO 3807/73A NO 380773 A NO380773 A NO 380773A NO 140186 C NO140186 C NO 140186C
Authority
NO
Norway
Prior art keywords
propylamines
chlorophenyl
pyridyl
preparation
new
Prior art date
Application number
NO3807/73A
Other languages
English (en)
Norwegian (no)
Other versions
NO140186B (no
Inventor
William John Welstead Jr
Burt Trosey Merriman Jr
Original Assignee
Robins Co Inc A H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robins Co Inc A H filed Critical Robins Co Inc A H
Publication of NO140186B publication Critical patent/NO140186B/no
Publication of NO140186C publication Critical patent/NO140186C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26Radicals substituted by halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/57Nitriles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO3807/73A 1972-10-02 1973-10-01 Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye 2-(2-pyridyl)-3-(p-klorfenyl)-propylaminer NO140186C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00293863A US3819641A (en) 1972-10-02 1972-10-02 2-(2-pyridyl)-omega-phenylalkylamines

Publications (2)

Publication Number Publication Date
NO140186B NO140186B (no) 1979-04-09
NO140186C true NO140186C (no) 1979-07-18

Family

ID=23130909

Family Applications (1)

Application Number Title Priority Date Filing Date
NO3807/73A NO140186C (no) 1972-10-02 1973-10-01 Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye 2-(2-pyridyl)-3-(p-klorfenyl)-propylaminer

Country Status (19)

Country Link
US (1) US3819641A (fr)
JP (1) JPS614832B2 (fr)
AT (1) AT329558B (fr)
AU (1) AU6067373A (fr)
BE (1) BE805529A (fr)
CA (1) CA1018169A (fr)
CH (1) CH583704A5 (fr)
DE (1) DE2349493A1 (fr)
DK (1) DK143981C (fr)
FI (1) FI56966C (fr)
FR (1) FR2201099B1 (fr)
GB (1) GB1440777A (fr)
IE (1) IE40373B1 (fr)
IL (1) IL43335A0 (fr)
NL (1) NL178787C (fr)
NO (1) NO140186C (fr)
PH (1) PH10660A (fr)
SE (1) SE394431B (fr)
ZA (1) ZA737710B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3923988A (en) * 1972-10-02 1975-12-02 Robins Co Inc A H 2-(2-pyridyl)-{107 -phenylalkylamines
US4562258A (en) * 1982-02-04 1985-12-31 Findlay John W A 6-[3-Amino-1-(4-tolyl)prop-1E-enyl]pyridine-2-carboxylic acid derivatives having antihistaminic activity
US4584382A (en) * 1983-02-01 1986-04-22 Findlay John W A Pyridyl acrylate compound
US4621094A (en) * 1983-03-10 1986-11-04 Findlay John W A Anti-histaminic pyridyl compounds
JPH0434982Y2 (fr) * 1986-11-21 1992-08-19
US5430044A (en) * 1987-02-06 1995-07-04 Fisons Corporation Arylalkyl-amines and -amides having anticonvulsant and neuroprotective properties
CN108314631A (zh) * 2018-04-19 2018-07-24 中国科学院昆明植物研究所 二芳基乙烯类化合物及其药物组合物和其应用

Also Published As

Publication number Publication date
ATA843073A (de) 1975-08-15
IL43335A0 (en) 1973-11-28
FI56966B (fi) 1980-01-31
NL178787B (nl) 1985-12-16
PH10660A (en) 1977-07-27
US3819641A (en) 1974-06-25
IE40373L (en) 1974-04-02
DE2349493A1 (de) 1974-04-18
JPS614832B2 (fr) 1986-02-13
BE805529A (fr) 1974-02-01
CA1018169A (en) 1977-09-27
AT329558B (de) 1976-05-25
DK143981C (da) 1982-04-26
FI56966C (fi) 1980-05-12
DK143981B (da) 1981-11-09
FR2201099B1 (fr) 1977-01-28
IE40373B1 (en) 1979-05-23
SE394431B (sv) 1977-06-27
FR2201099A1 (fr) 1974-04-26
CH583704A5 (fr) 1977-01-14
NL7313472A (fr) 1974-04-04
GB1440777A (en) 1976-06-23
JPS49132077A (fr) 1974-12-18
NL178787C (nl) 1986-05-16
NO140186B (no) 1979-04-09
AU6067373A (en) 1975-03-27
ZA737710B (fr) 1974-08-28

Similar Documents

Publication Publication Date Title
NO140056C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive olefinisk 4-substituerte piperidino-derivater
NO140059C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte piperidinderivater
NO140589C (no) Analogifremgangsmaate for fremstilling av nye, terapeutisk aktive 3,4-dihydrokarbostyrilderivater
NO138565C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive piperazinyl-propyl-1,2,4-triazolinonderivater
NO138566C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,1,3-benzotiadiazol-derivater
NO141687C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1-oxo-2,2-disubstituerte-5-indanyloxy-eddiksyrer
NO144743C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye penicillinderivater
NO142865C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive karbazoler
NO140058C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte piperidinoalkanol-oxim-derivater
NO143846C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive 1,4-dihydropyridinderivater
NO140977C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 2-amino-1,4-dihydropyridiner
NO140057C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive alfa-aryl-4-substituerte piperidinoalkanol-derivater
NO138599C (no) Analogifremgangsmaate til fremstilling av nye, terapeutisk virksomme tienopyrimidinderivater
NO141648C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive 2-oxazolinderivater
NO140348C (no) Analogifremgangsmaate til fremstilling av nye terapeutisk aktive 3-(amino-2-hydroksypropoksy)-isoindolin-1-on-forbindelser
NO140186C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye 2-(2-pyridyl)-3-(p-klorfenyl)-propylaminer
NO137550C (no) Analogifremgangsmaate til fremstilling av anti-inflammatorisk virksomme 2,4,5-trisubstituerte oksazolforbindelser
NO140670C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrazolodiazepinderivater
NO138660C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive nye 3-(piperazinalkyl)-2,4-kinazolindioner
FI55659B (fi) Foerfarande foer framstaellning av terapeutiskt aktiva 3-(4-substituerad-piperazin-1-ylkarbonyloxi)-2-(1,8-naftyridin-2-yl)isoindolin-1-oner
NO142077C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(1-cyclohexyl-3-pyrrolidinyl)-benzamider
NO140858C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive nye 2,4-diamino-5-benzyl-pyrimidinderivater
NO136840C (no) Analogifremgangsm}te til fremstilling av nye, terapeutisk aktive derivater av isoindolin
NO138568C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktivt 21-(bea-benzoylaminoisobutyryl)-16alfa,17alfa-(p-dimethyl-aminobenzyliden)-triamcinolon
NO137548C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive n-difenylpropyl-propylendiaminer